造影增强超声内镜与增强CT对胰腺实性占位诊断价值的比较分析
DOI: 10.3969/j.issn.1001-5256.2021.07.033
Value of contrast-enhanced endoscopic ultrasound versus contrast-enhanced computed tomography in the diagnosis of pancreatic solid space-occupying lesions
-
摘要:
目的 探讨造影增强超声内镜(CE-EUS)与增强CT(CE-CT)对胰腺实性占位的诊断价值。 方法 选取2014年1月—2019年12月就诊于首都医科大学附属北京天坛医院的胰腺实性占位患者78例,所有患者均经EUS引导下细针抽吸活检或手术后病理确诊,比较CE-EUS、CE-CT诊断胰腺实性占位的准确率、敏感度、特异度、Youden指数。 结果 CE-EUS、CE-CT诊断胰腺癌的正确率分别为97.9%、87.2%,敏感度分别为97.7%、88.9%,特异度分别为100%、50%,Youden指数分别为0.96、0.76;CE-EUS、CE-CT诊断小胰癌的准确率分别为84.6%、61.5%,敏感度分别为80%、70%,特异度分别为100%、33.3%,Youden指数分别为0.80、0.03;CE-EUS、CE-CT诊断慢性胰腺炎肿块的准确率分别为90.5%、61.9%,敏感度分别为94.1%、64.7%,特异度分别为75%、50%,Youden指数分别为0.69、0.15;CE-EUS、CE-CT诊断胰腺神经内分泌肿瘤的准确率分别为85.7%、28.6%,敏感度分别为83.3%、16.7%,特异度分别为100%、100%,Youden指数分别为0.83、0.17。 结论 在对胰腺实性占位的诊断方面,CE-EUS较CE-CT有明显优势。 -
关键词:
- 胰腺肿瘤 /
- 内分泌腺肿瘤 /
- 腔内超声检查 /
- 体层摄影术,X线计算机 /
- 诊断
Abstract:Objective To investigate the value of contrast-enhanced endoscopic ultrasound (CE-EUS) versus contrast-enhanced computed tomography (CE-CT) in the diagnosis of pancreatic solid space-occupying lesions. Methods A total of 78 patients with pancreatic solid space-occupying lesions who attended Beijing Tiantan Hospital, Capital Medical University, from January 2014 to December 2019 were enrolled. All patients were diagnosed by EUS-guided fine needle aspiration or postoperative pathology, and CE-EUS and CE-CT were compared in terms of their accuracy, sensitivity, specificity, and Youden index in the diagnosis of pancreatic solid space-occupying lesions. Results In the diagnosis of pancreatic cancer, CE-EUS and CE-CT had accuracy rates of 97.9% and 87.2%, sensitivities of 97.7% and 88.9%, specificities of 100% and 50%, and Youden indices of 0.96 and 0.76, respectively. In the diagnosis of small pancreatic cancer, CE-EUS and CE-CT had accuracy rates of 84.6% and 61.5%, sensitivities of 80% and 70%, specificities of 100% and 33.3%, and Youden indices of 0.80 and 0.03, respectively. In the diagnosis of chronic pancreatitis with mass, CE-EUS and CE-CT had accuracy rates of 90.5% and 61.9%, sensitivities of 94.1% and 64.7%, specificities of 75% and 50%, and Youden indices of 0.69 and 0.15, respectively. In the diagnosis of pancreatic neuroendocrine tumors, CE-EUS and CE-CT had accuracy rates of 85.7% and 28.6%, sensitivities of 83.3% and 16.7%, specificities of 100% and 100%, and Youden indices of 0.83 and 0.17, respectively. Conclusion CE-EUS has certain advantages over CE-CT in the diagnosis of pancreatic solid space-occupying lesions. -
表 1 CE-EUS与CE-CT诊断胰腺癌准确率比较
组别 病理学检查(例) 合计(例) 准确率(%) 敏感度(%) 特异度(%) Youden指数 阳性 阴性 CE-EUS 97.9 97.7 100.0 0.96 阳性 44 0 44 阴性 1 2 3 CE-CT 87.2 88.9 50.0 0.76 阳性 40 1 41 阴性 5 1 6 表 2 CE-EUS与CE-CT诊断小胰癌准确率比较
组别 病理学检查(例) 合计(例) 准确率(%) 敏感度(%) 特异度(%) Youden指数 阳性 阴性 CE-EUS 84.6 80.0 100.0 0.80 阳性 8 0 8 阴性 2 3 5 CE-CT 61.5 70.0 33.3 0.03 阳性 7 2 9 阴性 3 1 4 表 3 CE-EUS与CE-CT诊断慢性胰腺炎肿块准确率比较
组别 病理学检查(例) 合计(例) 准确率(%) 敏感度(%) 特异度(%) Youden指数 阳性 阴性 CE-EUS 90.5 94.1 75.0 0.69 阳性 16 1 17 阴性 1 3 4 CE-CT 61.9 64.7 50.0 0.15 阳性 11 2 13 阴性 6 2 8 表 4 CE-EUS与CE-CT诊断胰腺神经内分泌肿瘤诊断准确率比较
组别 金标准(例) 合计(例) 准确率(%) 敏感度(%) 特异度(%) Youden指数 阳性 阴性 CE-EUS 85.7 83.3 100.0 0.83 阳性 5 0 5 阴性 1 1 2 CE-CT 28.6 16.7 100.0 0.17 阳性 1 0 1 阴性 5 1 6 -
[1] LENNON AM, HRUBAN RH, KLEIN AP. Screening for pancreatic cancer-Is there hope?[J]. JAMA Intern Med, 2019, 179(10): 1313-1315. DOI: 10.1001/jamainternmed.2019.3323. [2] SIEGEL RL, MILLER KD, JEMAL A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30. DOI: 10.3322/caac.21442. [3] ANAIZI A, HART PA, CONWELL DL. Diagnosing chronic pancreatitis[J]. Dig Dis Sci, 2017, 62(7): 1713-1720. DOI: 10.1007/s10620-017-4493-2. [4] AZIZIAN A, RVHLMANN F, KRAUSE T, et al. CA19-9 for detecting recurrence of pancreatic cancer[J]. Sci Rep, 2020, 10(1): 1332. DOI: 10.1038/s41598-020-57930-x. [5] FANG X, BIAN Y, WANG L, et al. Significance and differential diagnosis of pancreatic imaging examination in clinical decision-making[J]. Chin J Dig Surg, 2020, 19(4): 449-454. DOI: 10.3760/cma.j.cn115610-20200409-00241.方旭, 边云, 王莉, 等. 胰腺影像学检查在临床决策中的意义及鉴别诊断[J]. 中华消化外科杂志, 2020, 19(4): 449-454. DOI: 10.3760/cma.j.cn115610-20200409-00241. [6] SRISAJJAKUL S, PRAPAISILP P, BANGCHOKDEE S. CT and MR features that can help to differentiate between focal chronic pancreatitis and pancreatic cancer[J]. Radiol Med, 2020, 125(4): 356-364. DOI: 10.1007/s11547-019-01132-7. [7] STORM AC, LEE LS. Endoscopic ultrasound-guided techniques for diagnosing pancreatic mass lesions: Can we do better?[J]. World J Gastroenterol, 2016, 22(39): 8658-8669. DOI: 10.3748/wjg.v22.i39.8658. [8] CAI BB, GAO Y, WANG GP, et al. Advances in diagnosis and treatment of pancreatic diseases of the Nanjing Pancreas Forum 2018[J]. Chin J Dig Surg, 2019, 18(1): Ⅲ-Ⅶ. DOI: 10.3760/cma.j.issn.1673-9752.2019.01.101.蔡宝宝, 杲勇, 王广甫, 等. Nanjing Pancreas Forum 2018: 胰腺疾病诊断与治疗进展解析[J]. 中华消化外科杂志, 2019, 18(1) : Ⅲ-Ⅶ. DOI: 10.3760/cma.j.issn.1673-9752.2019.01.101. [9] KITANO M, YOSHIDA T, ITONAGA M, et al. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer[J]. J Gastroenterol, 2019, 54(1): 19-32. DOI: 10.1007/s00535-018-1519-2. [10] LI Y, JIN H, LIAO D, et al. Contrast-enhanced harmonic endoscopic ultrasonography for the differential diagnosis of pancreatic masses: A systematic review and meta-analysis[J]. Mol Clin Oncol, 2019, 11(4): 425-433. DOI: 10.3892/mco.2019.1908. [11] MEI S, WANG M, SUN L. Contrast-enhanced EUS for differential diagnosis of pancreatic masses: A meta-analysis[J]. Gastroenterol Res Pract, 2019, 2019: 1670183. DOI: 10.1155/2019/1670183. [12] PULEO F, MARÉCHAL R, DEMETTER P, et al. New challenges in perioperative management of pancreatic cancer[J]. World J Gastroenterol, 2015, 21(8): 2281-2293. DOI: 10.3748/wjg.v21.i8.2281. [13] OKUSAKA T, NAKAMURA M, YOSHIDA M, et al. Clinical practice guidelines for pancreatic cancer 2019 from the Japan Pancreas Society: A synopsis[J]. Pancreas, 2020, 49(3): 326-335. DOI: 10.1097/MPA.0000000000001513. [14] LI XZ, SONG J, SUN ZX, et al. Diagnostic performance of contrast-enhanced ultrasound for pancreatic neoplasms: A systematic review and meta-analysis[J]. Dig Liver Dis, 2018, 50(2): 132-138. DOI: 10.1016/j.dld.2017.10.012.
计量
- 文章访问数: 718
- HTML全文浏览量: 583
- PDF下载量: 37
- 被引次数: 0